Skip to main content
LXRX
NASDAQ Life Sciences

Lexicon Banks Third $10M Milestone from Novo Nordisk as LX9851 Advances in Phase 1

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.38
Mkt Cap
$1.023B
52W Low
$1.03
52W High
$2.68
52W Position info
131% above low
Off High info
11% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LXRX has more than doubled off its 52-week low of $1.03.

Summary

Lexicon earned a third $10 million milestone payment from Novo Nordisk in 2026, triggered by a key patient dosing milestone in the Phase 1 study of LX9851, an oral ACSL5 inhibitor for obesity. This brings total milestone payments under the collaboration to $75 million of a potential $1 billion, plus tiered royalties. The payment is non-dilutive cash that strengthens Lexicon's balance sheet as it advances its own pipeline, including the pivotal SONATA-HCM study. Phase 1 completion for LX9851 is expected in Q1 2027, with further development milestones possible.

At the time of this announcement, LXRX was trading at $2.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $1.03 to $2.68. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

LXRX - Latest Insights

LXRX
Nov 05, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $1.50 info
Change: -$0.1106 (-7%) info
Market Cap: $681.209M info
LXRX
Nov 05, 2026, 7:03 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $1.50 info
Change: -$0.1075 (-7%) info
Market Cap: $681.209M info
LXRX
Nov 05, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $1.50 info
Change: -$0.1075 (-7%) info
Market Cap: $681.209M info
LXRX
Aug 31, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.50 info
Change: -$0.7975 (-35%) info
Market Cap: $681.209M info
LXRX
Aug 06, 2026, 7:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.95
Real-time Price: $1.50 info
Change: -$0.4475 (-23%) info
Market Cap: $681.209M info